Saudi Arabia tops in pharma investment

Saudi Arabia is the top country in the Middle East in terms of pharmaceutical investment, according to a new report from research and consulting firm GlobalData.

United Arab Emirates (UAE) finished in second place, with the creation of tax-exempt drug development zones helping to ensure growth prospects for the country.

Medical tourism, straightforward regulatory guidelines, and increasing healthcare expenditures will also be key drivers of UAE's pharmaceutical market, which could reach $3.7 billion by 2020, according to the report.

Page 1 of 3588
Next Page